Literature DB >> 15200011

Stability of liposomal formulations in physiological conditions for oral drug delivery.

M C Taira1, N S Chiaramoni, K M Pecuch, S Alonso-Romanowski.   

Abstract

The stability of liposomal formulations is a key issue in drug delivery. Liposomes made of egg phosphatidylcholine (EPC), cholesterol (Chol), sphingomyelin (SM), and gangliosides (GM1 and GM type III) were incubated in different media to determine their stability. Mixtures containing GM1 or GM type III were found to be the most stable, and both showed similar stability trends in plasma at 37 degrees C. EPC/Chol was the most susceptible to lysis in plasma. In acid media (pH 2), the highest stability corresponded to EPC/Chol, whereas in bile and pancreatin, liposomes with GM1 and GM type III were more stable than those containing SM. This study suggests that among the formulations used as oral drug carriers, those containing GM1 and GM type III have higher possibilities of surviving through the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15200011     DOI: 10.1080/10717540490280769

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  15 in total

Review 1.  Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.

Authors:  John C Kraft; Jennifer P Freeling; Ziyao Wang; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2013-11-25       Impact factor: 3.534

2.  Freeze-dried targeted mannosylated selenium-loaded nanoliposomes: development and evaluation.

Authors:  Susanne R Youngren; Rohit Mulik; Byoung Jun; Peter R Hoffmann; Kenneth R Morris; Mahavir B Chougule
Journal:  AAPS PharmSciTech       Date:  2013-09       Impact factor: 3.246

3.  Engineering polysaccharide-based polymeric micelles to enhance permeability of cyclosporin A across Caco-2 cells.

Authors:  Mira F Francis; Mariana Cristea; Yali Yang; Françoise M Winnik
Journal:  Pharm Res       Date:  2005-02       Impact factor: 4.200

4.  Development of Geraniol-Loaded Liposomal Nanoformulations against Salmonella Colonization in the Pig Gut.

Authors:  Sotirios I Ekonomou; Pooja Akshay Thanekar; Dimitrios A Lamprou; Edward Weaver; Olena Doran; Alexandros Ch Stratakos
Journal:  J Agric Food Chem       Date:  2022-06-02       Impact factor: 5.895

5.  Pulmonary delivery of osimertinib liposomes for non-small cell lung cancer treatment: formulation development and in vitro evaluation.

Authors:  Shruti S Sawant; Suyash M Patil; Snehal K Shukla; Nishant S Kulkarni; Vivek Gupta; Nitesh K Kunda
Journal:  Drug Deliv Transl Res       Date:  2021-11-23       Impact factor: 5.671

6.  A polymeric fastener can easily functionalize liposome surfaces with gadolinium for enhanced magnetic resonance imaging.

Authors:  Cartney E Smith; Artem Shkumatov; Sarah G Withers; Binxia Yang; James F Glockner; Sanjay Misra; Edward J Roy; Chun-Ho Wong; Steven C Zimmerman; Hyunjoon Kong
Journal:  ACS Nano       Date:  2013-10-11       Impact factor: 15.881

7.  Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept.

Authors:  Dimitrios Bitounis; Raphaelle Fanciullino; Athanassios Iliadis; Joseph Ciccolini
Journal:  ISRN Pharm       Date:  2012-02-09

8.  Cross-linkable liposomes stabilize a magnetic resonance contrast-enhancing polymeric fastener.

Authors:  Cartney E Smith; Hyunjoon Kong
Journal:  Langmuir       Date:  2014-03-25       Impact factor: 3.882

Review 9.  Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.

Authors:  Maria Laura Immordino; Franco Dosio; Luigi Cattel
Journal:  Int J Nanomedicine       Date:  2006

10.  Optimization and in vivo toxicity evaluation of G4.5 PAMAM dendrimer-risperidone complexes.

Authors:  Maria Jimena Prieto; Nahuel Eduardo del Rio Zabala; Cristian Hernán Marotta; Hector Carreño Gutierrez; Rosario Arévalo Arévalo; Nadia Silvia Chiaramoni; Silvia del Valle Alonso
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.